Integration Will Enable Approximately 450 Health Systems to Access the Galleri Test Results Within Their Existing Patient Portal
Collaboration With Epic Will Allow Clinicians to Seamlessly Order the Galleri Multi-Cancer Early Detection Test at the Point of Care
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced a collaboration with Epic to bring the Galleri® multi-cancer early detection test into one of the nation’s most widely used electronic health record (EHR) platforms, supporting broader adoption across health systems in the United States.
Epic is a leading EHR platform used by many of the largest and most advanced health systems. Integration through Epic Aura will allow interested health systems and their healthcare providers to order the Galleri test directly at the point of care, receive results, and manage patient follow-up seamlessly within their existing native EHR and within their existing clinical workflows. Through this integration, clinicians using Epic can access the Galleri test within their native EHR environment, helping to eliminate administrative burden, reduce manual processes, and improve the overall provider and patient experience.
“Today, recommended screening exists for only five cancers in the U.S., yet more than 70% of deaths are caused by cancers without a recommended screening test,” said Josh Ofman, MD, MSHS, President at GRAIL. “With a scalable integration through Epic, we are reducing operational barriers and making it easier for healthcare providers to incorporate the Galleri test into routine care, with the ultimate goal of supporting early cancer detection before symptoms appear, when outcomes may be better. GRAIL looks forward to collaborating with Epic as well as health systems, clinicians, and care teams as the integration process begins.”
Implementation planning began in the first quarter of 2026, including initial integrations and early adopter programs. GRAIL will work closely with Epic and AWS, the preferred cloud provider for GRAIL, along with any interested health systems, community healthcare providers, and retail health clinics to support workflow alignment, training and deployment success. Broad availability is expected by the end of 2026.
“Aura helps healthcare organizations collaborate by removing administrative barriers,” said Alan Hutchison, Vice President at Epic. “With GRAIL joining the Epic community, together with healthcare organizations, we can advance early detection and ultimately improve cancer survival rates.”
“Integrating Galleri directly into Epic enables us to incorporate multi-cancer early detection into routine clinical care in a seamless way for both providers and patients,” said Philip Oravetz, M.D., Chief Population Health Officer at Ochsner Health. “By embedding Galleri within our existing EHR infrastructure, we reduce administrative burden, support appropriate patient identification, and streamline ordering within established workflows. When breakthrough technologies are thoughtfully integrated into clinical practice, we can scale adoption responsibly, enhance the patient experience, improve care delivery, and further our commitment to proactive, population-focused health care.”
Health systems interested in learning more about the Galleri test are encouraged to visit www.galleri.com/health-systems
Explore AITechPark for the latest Artificial Intelligence News advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!